期刊文献+

酮基布洛芬分散片的制备及其体外溶出评价

Study on the preparation of ketoprofen dispersible tablets and its dissolution rate in vitro
原文传递
导出
摘要 目的:制备酮基布洛芬分散片,并考察其体外溶出度。方法:以微晶纤维素(MCC)为填充剂,采用湿法制粒法制备分散片;以MCC、羧甲基淀粉钠(CMS-Na)的处方用量及羟丙基甲基纤维素(HPMC)的浓度为因素,并采用正交试验设计优化处方;采用中国药典溶出度法第二法,以磷酸盐缓冲液为介质进行体外溶出度考察。结果:最佳处方为MCC30%、CMSNa3%、HPMC1%;所制片剂呈白色、片面光洁,崩解时限20s,含量、分散均匀性均符合中国药典2010年版相关要求,30min溶出度大于90%。结论:该分散片制备方法简单,分散均匀,溶出速度快且完全。 OBJECTIVE To prepare ketoprofen dispersible tablet and evaluate its dissolution rate in vitro. METHODS Ke- toprofen dispersible tablets were prepared with wet granulation using microcrystalline cellulose(MCC)as filler; the prescribed dosages of MCC and CMS-Na, the concentration of HPMC as factors, and the prescription was optimized by using orthogonal experimental design; the second determination method of dissolution rate stated in Chinese Pharmacopeia was adopted to deter- mine the in vitro dissolution rate of prepared tablets using phosphate buffer solution as solvent. RESULTS The optimized pre- scription was as follows: MCC30%, CMS-Na3%, HPMC1 %. Prepared tablets were characterized with primrose white and smooth appearance and disintegrating time of 20s. The content and disperse homogeneity of prepared tablets were in line with the requirement of Chinese Pharmacopeia(2010 edition). The dissolution rate of prepared tablets was more than 90% in 60 min. CONCLUSION The preparation method is simple, spread evenly and the dispersible tablets dissolve fast and completely.
出处 《中国医院药学杂志》 CAS CSCD 北大核心 2014年第7期547-549,583,共4页 Chinese Journal of Hospital Pharmacy
关键词 酮基布洛芬 分散片 正交试验 溶出度 ketoprofen dispersible tablet orthogonal test dissolution rate
  • 相关文献

参考文献5

  • 1Modi NB, Linfemulder B, Gupta SK. Single and multiple-dose pharmacokinetics of an oral once-a-day osmotic controlled-re- lease OROS (methylphenidate HC1)formulation[J].J Clin Pharmacol, 2000,40 (4) : 379.
  • 2Gupta SK, Shah JC, Hwang SS. Pharmacokinetics and phar- macodynamic characterization of OROS and immediate-release amitriptyline [ J]. Br J Clin pharmacoh 1999,48 ( 1 ) : 71.
  • 3Gupta SK, Shah JC, Guinta D, et al. Multiple-dose pharmacoki- netics and pharmacodynamics of OROS and immediate-release amitriptyline hydrocholoride formulation [J]. J Clin Pharma- col, 1998,38(1 ) :60.
  • 4中国药典.二部[S].2010:凡例ⅩⅦ.
  • 5王汝兴,许士奇,陈大为.酮基布洛芬单室型渗透泵片制备工艺的探讨[J].中国医院药学杂志,2006,26(3):304-306. 被引量:8

二级参考文献6

  • 1谷士杰.固体分散物在药剂学中的应用及其研究方法[J].药学通报,1985,20(2):108-108.
  • 2Modi NB,Linfemulder B,Gupta SK.Single and multiple-dose pharmacokinetics of an oral once-a-day osmotic controlled-release OROS (methylphenidate HC1)formulation [J].J Clin Pharmacol,2000,40 (4):379.
  • 3GuptaSK,ShahJC,HwangSS.Pharmacokinetics and pharmacodynamic characterization of OROS and immediate-release amitriptyline [J].Br J Clin pharmacol,1999,48 (1):71.
  • 4GuptaSK,Shah JC,GuintaD,etal.multiple-dose pharmacoki netics and pharmacodynamics of OROS and immediate-release amitriptyline hydrocholoride formulation [J].J Clin Pharmacol,1998,38(1):60.
  • 5戚海亮,隋晓平,高崇凯.酮洛芬缓释胶囊剂制备工艺正交设计实验及其体外释放特性研究[J].中国现代应用药学,1998,15(3):21-23. 被引量:6
  • 6程紫骅,庄洪波,武华丽,朱家璧.用乙基纤维素制备酮洛芬缓释固体分散体的研究[J].中国药科大学学报,1999,30(3):192-195. 被引量:23

共引文献166

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部